Understanding the Types of Muscular Dystrophy
Muscular dystrophy (MD) isn’t just one disease; it’s a group of genetic disorders that cause progressive muscle weakness and degeneration. Over time, these conditions limit mobility, impact vital bodily functions, and reduce quality of life. As the National Institute of Neurological Disorders and Stroke (2023) explains, “Muscular dystrophy (MD) refers to a group of genetic diseases that cause progressive weakness and degeneration of skeletal muscles used during voluntary movement.”
For families, patients, and researchers alike, understanding the differences among MD types is crucial. Each form has distinct symptoms, progression patterns, and care needs. Here’s a closer look at the major types of muscular dystrophy and why research into each one is essential.
Duchenne Muscular Dystrophy (DMD)
DMD is the most common and severe form of muscular dystrophy in children. It primarily affects boys, with symptoms typically appearing between ages 2 and 6. These include frequent falls, difficulty getting up, and muscle wasting. DMD is caused by mutations in the gene that makes dystrophin, a protein essential for muscle function (National Institute of Child Health and Human Development [NICHD], 2017).
Becker Muscular Dystrophy (BMD)
Becker muscular dystrophy is similar to Duchenne but less severe and slower to progress. It also stems from mutations in the dystrophin gene, but individuals with BMD produce some functional dystrophin, which helps delay symptoms (NICHD, 2017).
Myotonic Dystrophy (DM)
This is the most common adult-onset form of muscular dystrophy. It causes prolonged muscle contractions (myotonia), as well as issues in the heart, endocrine system, and eyes. DM is divided into type 1 and type 2, each caused by different genetic mutations (Centers for Disease Control and Prevention [CDC], 2020).
Limb-Girdle Muscular Dystrophy (LGMD)
LGMD includes more than 30 subtypes, all affecting the muscles around the hips and shoulders. It can begin in childhood or adulthood and may progress quickly or slowly, depending on the specific genetic cause (CDC, 2020).
Facioscapulohumeral Muscular Dystrophy (FSHD)
FSHD affects the muscles of the face, shoulders, and upper arms, often starting in adolescence or early adulthood. Symptoms can be subtle at first, such as difficulty smiling, lifting arms, or closing eyes (CDC, 2020).
Congenital Muscular Dystrophy (CMD)
CMD is typically present at birth or within the first year of life. It encompasses a group of muscular dystrophies that can involve issues with brain development or severe muscle weakness early in life (CDC, 2020).
Emery-Dreifuss Muscular Dystrophy (EDMD)
EDMD is marked by a trio of symptoms: joint contractures (stiff joints), muscle weakness, and heart problems, particularly cardiac conduction defects (CDC, 2020).
Oculopharyngeal Muscular Dystrophy (OPMD)
OPMD typically appears in middle to late adulthood and begins with weakness in the eyelids and throat muscles, leading to drooping eyelids and difficulty swallowing (CDC, 2020).
Distal Muscular Dystrophy (DD)
DD primarily affects muscles farthest from the center of the body, such as the hands, forearms, feet, and lower legs. It usually has a slower progression and may not appear until adulthood (CDC, 2020).
The Path Forward: Research and Advocacy
Recognizing the type of muscular dystrophy is essential for delivering the best care and for advancing research. As NINDS (2023) notes, while all MD types involve “progressive weakness and degeneration of skeletal muscles,” the underlying genetic mutations and clinical presentations vary widely. This diversity is why personalized research is so vital.
Medical research into CRISPR gene editing is on the cusp of breakthroughs. But these advancements rely heavily on continued funding and awareness. Every donation supports the scientists, clinicians, and advocates working tirelessly to change the lives of individuals with muscular dystrophy. By deepening our understanding of each MD type, we get one step closer to effective treatments and ultimately, a cure.
Together, we can turn knowledge into action and hope into healing. Donate today to support ongoing MD research.
References
Centers for Disease Control and Prevention. (2020, August 24). Types of muscular dystrophy. U.S. Department of Health & Human Services. https://www.cdc.gov/muscular-dystrophy/types/index.html
National Institute of Child Health and Human Development. (2017, May 1). What are the types of muscular dystrophy? National Institutes of Health. https://www.nichd.nih.gov/health/topics/musculardys/conditioninfo/typesNational Institute of Neurological Disorders and Stroke. (2023, December 14). Muscular dystrophy fact sheet. National Institutes of Health. https://www.ninds.nih.gov/health-information/disorders/muscular-dystrophy
